Live Breaking News & Updates on Intracoronary Gene Therapy

Stay updated with breaking news from Intracoronary gene therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)

GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy ....

United States , Jude Samulski , Roger Hajjar , Lothar Roessig , Asklepios Biopharmaceutical Inc , American Heart Association , Centers For Disease , Product Team Lead , Global Public Health Burden Of Heart Failure , York Heart Association , Bayer Ag , Asklepios Biopharmaceutical , Inhibition Therapy , New York Heart Association , Scientific Chair , Integrated Product Team Lead , Chief Scientific Officer , Viralgen Vector Core , Congestive Heart Failure , Intracoronary Gene Therapy , Subjects With Non Ischemic , Accessed January , Disease Control , Heart Association , Public Health Burden , Card Fail ,